Position in AMRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,506,764
+$1,022,859 QoQ
Shares Held
144,816
+21.3% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#97
of 305 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $21,925,909 across 23 Drug Manufacturers - Specialty & Generic names. AMRX ranks #4 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
159,508 | $5,530,142 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
55,058 | $4,557,701 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
255,600 | $2,556,000 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
144,816 | $2,506,764 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,292 | $1,241,874 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
22,143 | $908,527 | |
| 7 | PRGO |
PERRIGO Co plc
|
75,700 | $786,523 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
14,800 | $535,760 |
All Filings in AMRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,506,764 | 144,816 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,483,905 | 119,381 | Shares | Sole | 2026-05-12 | |
| 2025-09-30 | $304,454 | 30,415 | Shares | Sole | 2025-11-13 | |
| 2023-09-30 | $219,110 | 51,922 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $59,110 | 19,068 | Shares | Sole | 2023-08-14 | |
| 2021-06-30 | $69,079 | 13,492 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $84,367 | 12,536 | Shares | Sole | 2021-07-21 | |
| 2020-09-30 | $124,431 | 32,070 | Shares | Sole | 2020-10-30 | |
| No filing history on record for this holder in this stock. | ||||||